About HAL Allergy
One of the European top players in the field of allergy immunotherapy
Over the years HAL Allergy grew to one of the European top players in the field of allergen immunotherapy and has an internationally leading role in the production of modified allergen extracts for both, therapeutic and diagnostic purposes. For this purpose HAL Allergy established a state-of-the-art GMP production in the Leiden Bio Science Park in 2009, enabling increased production capacities.
In terms of technology, cutting-edge equipment is installed and the laboratory utilizes advanced equipment. This allows HAL Allergy to further improve its future growth demands and continue on its mission to improve the quality of life of patients by providing biopharmaceutical products for causal treatment.